Enanta Pharma
Stock
Stock
ISIN: US29251M1062
Ticker: ENTA
US29251M1062
ENTA
Price
Price
CHART BY
Frequently asked questions
What is Enanta Pharma's market capitalization?
The market capitalization of Enanta Pharma is $127.38M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Enanta Pharma?
Enanta Pharma's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$5.486. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Enanta Pharma's stock?
Currently, 8 analysts cover Enanta Pharma's stock, with a consensus target price of $15.75. Analyst ratings provide insights into the stock's expected performance.
What is Enanta Pharma's revenue over the trailing twelve months?
Over the trailing twelve months, Enanta Pharma reported a revenue of $67.64M.
What is the EBITDA for Enanta Pharma?
Enanta Pharma's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$119.36M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Enanta Pharma?
Enanta Pharma has a free cash flow of -$96.71M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Enanta Pharma have, and what sector and industry does it belong to?
Enanta Pharma employs approximately 131 people. It operates in the Health Care sector, specifically within the Pharmaceuticals: Major industry.
What is the free float of Enanta Pharma's shares?
The free float of Enanta Pharma is 19.73M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $127.38M
- EPS (TTM)
- -$5.486
- Free Float
- 19.73M
- Revenue (TTM)
- $67.64M
- EBITDA (TTM)
- -$119.36M
- Free Cashflow (TTM)
- -$96.71M
Pricing
- 1D span
- $5.883$6.151
- 52W span
- $5.71$17.79
Analyst Ratings
The price target is $15.75 and the stock is covered by 8 analysts.
Buy
4
Hold
3
Sell
1
Information
Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also conducts research in human metapneumovirus (hMPV) and SARS-CoV-2 (COVID-19). The company was founded by Peter O. Kliem Martin Karplus, James Hogle, Gerard Wagner, Peter M. Howley, and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.
- Employees
- 131
- Industries
- Pharmaceuticals: Major
- Sector
- Health Care
Identifier
- ISIN
- US29251M1062
- Primary Ticker
- ENTA